论文部分内容阅读
目的:探讨结肠癌、直肠癌活检病理诊断的价值。方法:选择2015年3月到2016年3月作为此次研究的时间段,在此时间段内选择本院收治的160例结肠癌、直肠癌患者进行研究,对所有患者均进行肠道内镜辅助下提取患者病灶组织进行活检,了解患者病灶癌变状况及肠道黏膜浸润状况,并将手术病理检查结果作为金标准,统计对比活检与手术病理检查的效果。结果:采取术前活检病理诊断确诊结肠、直肠癌151例,占94.4%;确诊腺瘤癌变9例,占5.6%。采取活检病理诊断的准确率为100.0%。结肠、直肠癌患者中92例患者存在肠道黏膜下层浸润状况,占60.9%。160例患者采取手术治疗后,159例患者痊愈出院,1例患者死亡。结论:结肠癌、直肠癌活检病理诊断可及时了解患者疾病类型,可有效辅助患者的手术治疗过程。
Objective: To investigate the value of pathological diagnosis of colorectal cancer and colorectal cancer biopsy. METHODS: From March 2015 to March 2016, we selected the time period of this study. 160 patients with colon cancer and rectal cancer admitted to our hospital during this time period were enrolled in this study. All patients underwent endoscopy Assisted with the extraction of the patient’s tissue for biopsy to understand the patient’s cancerous lesions and intestinal mucosal infiltration, and the results of surgical pathology as the gold standard, statistical contrast between biopsy and surgical pathology results. Results: 151 cases of colon and rectum diagnosed by preoperative biopsy were diagnosed, accounting for 94.4%; 9 cases were diagnosed as adenoma, accounting for 5.6%. The diagnostic accuracy of biopsy was 100.0%. 92 cases of colon, rectal cancer patients with intestinal submucosal invasion, accounting for 60.9%. Of the 160 patients who underwent surgery, 159 were discharged and one patient died. Conclusion: The diagnosis of colorectal cancer and colorectal cancer biopsy can be timely understanding of the patient’s disease type, which can effectively assist the patient’s surgical treatment process.